Sign in
RGC Stock Price, Chart, Stats & News
Regencell Bioscience Holdings Limited
Save
11.74B
Market cap
–
Current P/E
–
Forward P/E
RGC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -62.27% |
ROE | -61.93% |
D/E | 0.11x |
Interest coverage ratio | – |
RGC valuation
P/E | – |
P/S | – |
P/B | 2611.69x |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | -35.42x |
EV multiple | -3619.22x |
About
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Similar securities
Based on sector and market capitalization
Report issue